Donepezil in Chronic Poststroke Aphasia: a Randomized Controlled Trial


Phase 4 Results

Summary of Purpose

- Aphasia (impairment of language function due to brain damage)may be treated with speech-language therapy and drugs. Several drugs have been studied but with limited success. - Recent data suggest that the neurotransmitter acetylcholine may be reduced in brain damaged subjects and that drugs that stimulates acetylcholine activity may help recovery of aphasic deficits particularly...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 September 2005.

1 Feb 2003 12 Sep 2005 Unavailable 1 Mar 2005 1 Sep 2005 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available